Anti-inflammatory drugs

Methoxyflavones, particularly 5,7,3',4'-Tetramethoxyflavone, are used to inhibit IL-6 and TNF-α production, addressing persistent inflammation in elderly individuals and reducing inflammatory markers, showing efficacy in cell and animal models.

JP2026116005APending Publication Date: 2026-07-09NAT UNIV CORP EHIME UNIV +1
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
JP2024233106
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2024-12-27
Publication Date
2026-07-09

Smart Images

  • Figure 2026116005000038
    Figure 2026116005000038
  • Figure 2026116005000039
    Figure 2026116005000039
  • Figure 2026116005000040
    Figure 2026116005000040
Patent Text Reader

Abstract

The present invention provides an anti-inflammatory agent containing a specific methoxyflavone. [Solution] An anti-inflammatory agent (excluding intestinal barrier function improving agents) comprising a compound represented by formula (II), or a pharmaceutically acceptable salt, glycoside, or esterified thereof: TIFF2026116005000037.tif60170 (In the formula, R 1 , R 2 , R 3 , R 4 , and R 5 represents a linear or branched alkyl group having 1 to 6 carbon atoms. l, m, n, p, and q represent 0, 1, or 2. However, the sum of l, m, and n is 3 or less. The sum of p and q is 2 or less.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Oral composition for antiallergic

    JP2015036369A

  • Oral composition for antiallergic

    JP2016169219A

  • Intestinal tract barrier improver

    JP2021120359A

  • Oral composition

    JP2024003411A

  • Outdoor unit for air conditioner

    JP2024120359A